Risankizumab 68225-0226
Product NDC
68225-0226- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- June 16, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 60 mg/mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (68225-226-00) / 10 mL in 1 VIAL, SINGLE-DOSE